Yeim Sunthareth, Bordachar Pierre, Reuter Sylvain, Laborderie Julien, O'Neill Mark D, Lafitte Stephane, Deplagne Antoine, Garrigue Stephane, Roudaut Raymond, Jais Pierre, Haissaguerre Michel, Dossantos Pierre, Clementy Jacques
Hospital Haut Leveque, Service Pr Clementy, Pessac, France.
Pacing Clin Electrophysiol. 2007 Aug;30(8):970-5. doi: 10.1111/j.1540-8159.2007.00794.x.
Cardiac resynchronization therapy (CRT) is recommended in patients with ejection fraction <35%, QRS width> 120 ms, and New York Heart Association (NYHA) functional class III or IV despite optimal medical therapy. We aimed to define demographic, clinical, and electrocardiographic predictors of positive clinical response to CRT.
Hundred consecutive patients fulfilling the recommended criteria were implanted with a CRT device. Demographic, clinical, two-dimensional echocardiographic and electrographic parameters were measured at baseline and after 6 months of simultaneous biventricular pacing. A positive response to CRT included an improvement of at least one NYHA functional class associated with an absence of hospitalization for worsening heart failure. At the end of follow-up, 12 patients were dead and 71% of the patients were classified as responders. After 6 months of CRT, the ejection fraction was significantly higher (P = 0.035) in responders versus nonresponders. Multivariate analysis identified three independent predictors of positive response to CRT: an idiopathic origin of the cardiomyopathy (P = 0.043), a wider QRS before implantation (P = 0.017), and a narrowing of the QRS after implantation (P = 0.037).
An idiopathic origin of the cardiomyopathy, a wider QRS before implantation, and a narrowing of the QRS width after implantation were identified as independent predictors of clinical positive response to CRT.
对于射血分数<35%、QRS波宽度>120毫秒且纽约心脏协会(NYHA)心功能分级为III或IV级的患者,尽管接受了最佳药物治疗,仍推荐进行心脏再同步治疗(CRT)。我们旨在确定CRT临床阳性反应的人口统计学、临床和心电图预测因素。
连续100例符合推荐标准的患者植入了CRT设备。在基线时以及双心室同步起搏6个月后,测量了人口统计学、临床、二维超声心动图和心电图参数。CRT的阳性反应包括至少改善一个NYHA心功能分级且无因心力衰竭恶化而住院的情况。随访结束时,12例患者死亡,71%的患者被归类为反应者。CRT治疗6个月后,反应者的射血分数显著高于无反应者(P = 0.035)。多变量分析确定了CRT阳性反应的三个独立预测因素:心肌病的特发性起源(P = 0.043)、植入前较宽的QRS波(P = 0.017)以及植入后QRS波变窄(P = 0.037)。
心肌病的特发性起源、植入前较宽的QRS波以及植入后QRS波宽度变窄被确定为CRT临床阳性反应的独立预测因素。